Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Manuel Alba sold 37,000 shares of the business’s stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of $50.32, for a total transaction of $1,861,840.00. Following the completion of the sale, the director now owns 498,863 shares in the company, valued at $25,102,786.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Manuel Alba also recently made the following trade(s):
- On Friday, September 20th, Manuel Alba sold 63,000 shares of Astera Labs stock. The shares were sold at an average price of $50.00, for a total value of $3,150,000.00.
Astera Labs Stock Up 0.9 %
Shares of NASDAQ:ALAB traded up $0.47 on Tuesday, hitting $51.17. The company’s stock had a trading volume of 1,687,076 shares, compared to its average volume of 2,546,926. The firm’s 50-day moving average price is $44.10. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $95.21.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Amalgamated Bank acquired a new position in Astera Labs in the second quarter valued at approximately $74,000. Newbridge Financial Services Group Inc. grew its stake in shares of Astera Labs by 11,920.0% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 3,005 shares of the company’s stock valued at $182,000 after purchasing an additional 2,980 shares during the last quarter. Legato Capital Management LLC purchased a new position in Astera Labs in the second quarter worth $207,000. Alpine Global Management LLC purchased a new stake in shares of Astera Labs in the first quarter valued at about $272,000. Finally, Strategic Blueprint LLC acquired a new position in shares of Astera Labs in the second quarter valued at approximately $332,000.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the stock. Evercore ISI dropped their price objective on shares of Astera Labs from $98.00 to $80.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Astera Labs from $85.00 to $60.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Stifel Nicolaus lowered their price target on shares of Astera Labs from $87.00 to $80.00 and set a “buy” rating on the stock in a research report on Monday, August 5th. Needham & Company LLC decreased their price target on shares of Astera Labs from $85.00 to $65.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Finally, Morgan Stanley raised shares of Astera Labs from an “equal weight” rating to an “overweight” rating and set a $55.00 target price on the stock in a report on Wednesday, September 4th. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $71.36.
Read Our Latest Report on ALAB
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- What is a Secondary Public Offering? What Investors Need to Know
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Investing in Commodities: What Are They? How to Invest in Them
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.